Annual report pursuant to Section 13 and 15(d)

Investment (Tables)

v3.20.4
Investment (Tables)
12 Months Ended
Sep. 30, 2020
Investment  
Schedule of carrying value of the Company's total investment in DepYmed

The carrying value of the Company’s total investment is DepYmed is as follows:

 

 

 

 

 

 

 

 

 

 

As of September 30, 

 

    

2020

    

2019

Fair value of DepYmed common shares assumed in connection with acquisition of Ohr

 

$

487,398

 

$

487,398

Equity in losses on equity method investment

 

 

(262,861)

 

 

 —

Carrying value of DepYmed common shares

 

 

224,537

 

 

487,398

Fair value of DepYmed preferred shares assumed in connection with   acquisition of Ohr

 

 

99,020

 

 

99,020

Total Investment

 

$

323,557

 

$

586,418